First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 0.2449 USD -4.71% Market Closed
Updated: Apr 24, 2024

Yield10 Bioscience Inc
Net Income (Common)

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Yield10 Bioscience Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Yield10 Bioscience Inc
NASDAQ:YTEN
Net Income (Common)
-$14.5m
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
7%
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$4.8B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$5.7B
CAGR 3-Years
258%
CAGR 5-Years
1%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Yield10 Bioscience Inc's Net Income (Common)?
Net Income (Common)
-14.5m USD

Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Net Income (Common) amounts to -14.5m USD.

What is Yield10 Bioscience Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
7%

Over the last year, the Net Income (Common) growth was -7%. The average annual Net Income (Common) growth rates for Yield10 Bioscience Inc have been -12% over the past three years , -9% over the past five years , and 7% over the past ten years .